"Fenoldopam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Descriptor ID |
D018818
|
| MeSH Number(s) |
D03.633.100.079.300
|
| Concept/Terms |
SK&F-82526- SK&F-82526
- SK&F 82526
- SK&F82526
- SKF-82526
- SKF 82526
- SKF82526
SKF-82526J- SKF-82526J
- SKF 82526J
- SKF82526J
- SK&F-82526J
- SK&F 82526J
- SK&F82526J
|
Below are MeSH descriptors whose meaning is more general than "Fenoldopam".
Below are MeSH descriptors whose meaning is more specific than "Fenoldopam".
This graph shows the total number of publications written about "Fenoldopam" by people in this website by year, and whether "Fenoldopam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fenoldopam" by people in Profiles.
-
Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):587-92.
-
Immunohistochemical study on inducible type of nitric oxide (iNOS), basic fibroblast growth factor (bFGF) and tumor growth factor-beta1 (TGF-beta1) in arteritis induced in rats by fenoldopam and theophylline, vasodilators. Exp Toxicol Pathol. 2002 Jul; 54(1):1-7.
-
Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats. Exp Toxicol Pathol. 2001 Apr; 53(1):25-30.
-
Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993 Aug; 95(2):161-8.
-
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Intern Med. 1992 Dec; 152(12):2445-8.
-
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans. Clin Pharmacol Ther. 1991 Mar; 49(3):285-93.
-
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation. 1990 Mar; 81(3):970-7.
-
Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med. 1990 Jan; 18(1 Pt 2):S14-8.
-
Effects of dopamine receptor activation on the level of cyclic AMP in the trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jun; 30(6):1090-4.
-
Effects of selective dopamine-1 receptor activation on intraocular pressure in man. Exp Eye Res. 1988 Nov; 47(5):689-97.